DK1294747T3 - Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf - Google Patents

Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf

Info

Publication number
DK1294747T3
DK1294747T3 DK01945484T DK01945484T DK1294747T3 DK 1294747 T3 DK1294747 T3 DK 1294747T3 DK 01945484 T DK01945484 T DK 01945484T DK 01945484 T DK01945484 T DK 01945484T DK 1294747 T3 DK1294747 T3 DK 1294747T3
Authority
DK
Denmark
Prior art keywords
methods
aplidine
preparing
new antitumoral
derivatives
Prior art date
Application number
DK01945484T
Other languages
Danish (da)
English (en)
Inventor
Paloma Mendez
Lopez Maria Teresa Garcia
Rodriguez Marta Gutierrez
Herranz Rosario Herranz
Ignacio Rodriguez
Concepci N Polanco
Felix Cuevas
Carmen Cuevas
Pilar Gallego
Simon Munt
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016148A external-priority patent/GB0016148D0/en
Priority claimed from GB0103750A external-priority patent/GB0103750D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK1294747T3 publication Critical patent/DK1294747T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
DK01945484T 2000-06-30 2001-07-02 Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf DK1294747T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016148A GB0016148D0 (en) 2000-06-30 2000-06-30 Synthetic methods for aplidine and new antitiumoral derivatives
GB0103750A GB0103750D0 (en) 2001-02-15 2001-02-15 Synthetic methods for aplidine and new antitumoral derivatives methods of making and using them
PCT/GB2001/002901 WO2002002596A2 (en) 2000-06-30 2001-07-02 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them

Publications (1)

Publication Number Publication Date
DK1294747T3 true DK1294747T3 (da) 2008-10-27

Family

ID=26244577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945484T DK1294747T3 (da) 2000-06-30 2001-07-02 Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf

Country Status (25)

Country Link
US (2) US7348310B2 (he)
EP (1) EP1294747B1 (he)
JP (1) JP5289662B2 (he)
KR (1) KR100866056B1 (he)
CN (2) CN104650177A (he)
AT (1) ATE393775T1 (he)
AU (1) AU6769801A (he)
BR (1) BRPI0112375B8 (he)
CA (1) CA2414609C (he)
CY (1) CY1108549T1 (he)
CZ (1) CZ304204B6 (he)
DE (1) DE60133817T2 (he)
DK (1) DK1294747T3 (he)
ES (1) ES2305083T3 (he)
HK (1) HK1052940B (he)
HU (1) HU228998B1 (he)
IL (2) IL153680A0 (he)
MX (1) MXPA03000202A (he)
NO (1) NO334096B1 (he)
NZ (1) NZ523367A (he)
PL (1) PL208651B1 (he)
PT (1) PT1294747E (he)
SI (1) SI1294747T1 (he)
UA (1) UA76718C2 (he)
WO (1) WO2002002596A2 (he)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
SI1229922T1 (sl) * 1999-11-15 2008-04-30 Pharma Mar Sa Zdravljenje raka z aplidinom
US6509315B1 (en) 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
AU2001251498A1 (en) 2000-04-07 2001-10-23 The Trustees Of The University Of Pennsylvania Tamandarin and didemnin analogs and methods of making and using them
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
US7507766B2 (en) 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
RU2341283C2 (ru) 2003-03-12 2008-12-20 Фарма Мар, С.А. Усовершенствованное лечение опухолей
DE602004016126D1 (de) 2003-03-12 2008-10-09 Dana Farber Cancer Inst Inc Aplidine zur behandlung von multiplem myelom
MXPA05010064A (es) 2003-03-21 2006-05-17 Madeleine M Joullie Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos.
WO2007100385A2 (en) * 2005-10-31 2007-09-07 Genentech, Inc. Macrocyclic depsipeptide antibody-drug conjugates and methods
HUE028055T2 (en) * 2006-02-28 2016-11-28 Pharma Mar Sa Improved treatment of myeloma multiplex
CA2703024A1 (en) * 2007-10-19 2009-04-23 Giuseppe Longo Sorbello Improved antitumoral treatments
RU2010140888A (ru) * 2008-03-07 2012-04-20 Фарма Мар, С.А. (Es) Улучшенные противораковые терапии
WO2011020913A2 (en) 2009-08-21 2011-02-24 Pharma Mar, S.A. Cyclodepsipeptide antiviral compounds
JP2013537181A (ja) * 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
WO2021175826A1 (en) 2020-03-02 2021-09-10 Pharma Mar, S.A. Compounds for use in the treatment of coronavirus infection
JP2023517194A (ja) 2020-03-02 2023-04-24 ファルマ、マール、ソシエダード、アノニマ コロナウイルス感染の処置における組合せに使用するためのｐｌｄ
US20230158104A1 (en) 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in autoimmune conditions
MX2022010921A (es) 2020-03-02 2022-09-29 Pharma Mar Sa Compuestos para su uso en afecciones inflamatorias.
CN115594739A (zh) * 2021-06-28 2023-01-13 浙江珲达生物科技有限公司（Cn） 一种dehydrodidemnin B类化合物的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
DE3161556D1 (en) 1980-09-12 1984-01-05 Univ Illinois Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4948791A (en) 1989-04-10 1990-08-14 The Board Of Trustees Of The University Of Illinois Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
DE4120327A1 (de) * 1991-06-20 1992-12-24 Basf Ag Neue peptide, ihre herstellung und verwendung
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US6509316B2 (en) * 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
ES2102322B1 (es) * 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
ATE196844T1 (de) * 1996-05-22 2000-10-15 Protarga Inc Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
CA2269881A1 (en) * 1996-10-24 1998-04-30 The Board Of Trustees Of The University Of Illinois Semi-synthetic studies toward didemnin analogues
ATE245435T1 (de) * 1996-10-24 2003-08-15 Univ Illinois Totalsynthese des amino hip analogen von didemnin a
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
ES2321462T3 (es) * 1997-05-07 2009-06-05 Pharma Mar, S.A. Uso de aplidina para el tratamiento de enfermedades cardiovasculares.
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
AU764807B2 (en) 1998-07-30 2003-08-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
CA2373643A1 (en) 1999-05-25 2000-11-30 Point Therapeutics, Inc. Anti-tumor comprising boroproline compounds
SI1229922T1 (sl) 1999-11-15 2008-04-30 Pharma Mar Sa Zdravljenje raka z aplidinom
AU2001251498A1 (en) * 2000-04-07 2001-10-23 The Trustees Of The University Of Pennsylvania Tamandarin and didemnin analogs and methods of making and using them
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
MXPA03003230A (es) 2000-10-12 2004-12-03 Pharma Mar Sa Tratamiento de canceres.
EP1435991B1 (en) 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
RU2341283C2 (ru) 2003-03-12 2008-12-20 Фарма Мар, С.А. Усовершенствованное лечение опухолей

Also Published As

Publication number Publication date
BRPI0112375B8 (pt) 2021-05-25
US7348310B2 (en) 2008-03-25
CZ304204B6 (cs) 2014-01-02
HUP0301387A3 (en) 2005-04-28
PL208651B1 (pl) 2011-05-31
CN104650177A (zh) 2015-05-27
MXPA03000202A (es) 2003-10-15
DE60133817D1 (de) 2008-06-12
EP1294747A2 (en) 2003-03-26
JP5289662B2 (ja) 2013-09-11
BRPI0112375B1 (pt) 2020-12-01
WO2002002596A3 (en) 2002-05-23
WO2002002596A2 (en) 2002-01-10
HK1052940A1 (en) 2003-10-03
JP2004502702A (ja) 2004-01-29
US20080009435A1 (en) 2008-01-10
NO334096B1 (no) 2013-12-09
NO20026242L (no) 2003-02-27
NZ523367A (en) 2004-12-24
PL360531A1 (en) 2004-09-06
KR20030013477A (ko) 2003-02-14
DE60133817T2 (de) 2009-05-20
CY1108549T1 (el) 2014-04-09
CZ20024233A3 (cs) 2003-06-18
KR100866056B1 (ko) 2008-10-30
SI1294747T1 (sl) 2008-12-31
HK1052940B (zh) 2008-10-24
CA2414609A1 (en) 2002-01-10
UA76718C2 (uk) 2006-09-15
ATE393775T1 (de) 2008-05-15
NO20026242D0 (no) 2002-12-27
US7678765B2 (en) 2010-03-16
US20040097413A1 (en) 2004-05-20
HUP0301387A2 (hu) 2003-08-28
HU228998B1 (en) 2013-07-29
ES2305083T3 (es) 2008-11-01
CN1449408A (zh) 2003-10-15
PT1294747E (pt) 2008-08-08
CA2414609C (en) 2012-04-24
BR0112375A (pt) 2003-06-24
AU6769801A (en) 2002-01-14
IL153680A0 (en) 2003-07-06
EP1294747B1 (en) 2008-04-30
IL153680A (he) 2012-05-31

Similar Documents

Publication Publication Date Title
DK1294747T3 (da) Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
NO20014485D0 (no) Nye forbindelser og sammensetninger som proteaseinhibitorer
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20055741L (no) Nye kjemiske forbindelser
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE328883T1 (de) Imidazopyridin-8-one
TW200505413A (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
SE0301798D0 (sv) New use IV